Epidemiological and virological characterization of influenza B virus infections

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Sharabi, Sivan ^a,b   Drori, Yaron ^a,b   Micheli, Michal ^a   Friedman, Nehemya ^a,b   Orzitzer, Sara ^a   Bassal, Ravit ^a   Glatman Freedman, Aharona ^a,c   Shohat, Tamar ^a,b   Mendelson, Ella ^a,b   Hindiyeh, Musa ^a,b   Mandelboim, Michal ^a,b  

^a MINISTRY OF HEALTH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA B; INFLUENZA B VIRUS; ISRAELI; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SEX DIFFERENCE; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS GENOME; AGED; BLOOD; CLASSIFICATION; CROSS PROTECTION; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; ISRAEL; MIDDLE AGED; PRESCHOOL CHILD; SEASON; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS PROTECTION; FEMALE; GENOME, VIRAL; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISRAEL; MALE; MIDDLE AGED; PHYLOGENY; SEASONS; YOUNG ADULT;

EID: 84984858147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161195     Document Type: Article

References (28)

1. Nicholson KG, Wood JM, Zambon M (2003) Influenza. Lancet 362:1733-1745. PMID: 14643124
2. Wright PNG, Kawaoka Y (2006) Orthomyxoviruses. In Fields Virology 5th edition: 1691-1740.
3. Neumann GNT, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931-939. doi: 10.1038/nature08157 PMID: 19525932
4. Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA (2000) Influenza B virus in seals. Science 288:1051-1053. PMID: 10807575
5. Ambrose CS, Levin MJ (2012) The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 8:81-88. doi: 10.4161/hv. 8.1.17623 PMID: 22252006
6. Kim YH, Kim HS, Cho SH, Seo SH (2009) Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus. Viral Immunol 22:423-430. doi: 10.1089/vim. 2009.0045 PMID: 19951179
7. Wright PF, Bryant JD, Karzon DT (1980) Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis 141:430-435. PMID: 7373080
8. Wu CT, Hsia SH, Huang JL (2010) Influenza B-associated rhabdomyolysis in Taiwanese children. Acta Paediatr 99:1701-1704. doi: 10.1111/j.1651-2227.2009.01595.x PMID: 19912140
9. Taubenberger JK, Morens DM (2008) The pathology of influenza virus infections. Annu Rev Pathol 3:499-522. PMID: 18039138
10. Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, et al. (1990) Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season. J Virol 64:2860-2865. PMID: 2335820
11. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K (1990) Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175:59-68. PMID: 2309452
12. Chen R, Holmes EC (2008) The evolutionary dynamics of human influenza B virus. J Mol Evol 66:655-663. doi: 10.1007/s00239-008-9119-z PMID: 18504518
13. Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, George KS, et al. (2006) Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog 2:e125. PMID: 17140286
14. Meningher T, Hindiyeh M, Regev L, Sherbany H, Mendelson E, Mandelboim M (2014) Relationships between A (H1N1) pdm09 influenza infection and infections with other respiratory viruses. Influenza Other Respir Viruses 8:422-430. doi: 10.1111/irv. 12249 PMID: 24698156
15. Hindiyeh M, Levy V, Azar R, Varsano N, Regev L, Shalev Y, et al. (2005) Evaluation of a multiplex realtime reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel. J Clin Microbiol 43:589-595. PMID: 15695650
16. Biere B, Bauer B, Schweiger B (2010) Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol 48:1425-1427. doi: 10.1128/JCM.02116-09 PMID: 20107085
17. Drummond AJ, Suchard MA, Xie D, Rambaut A (2012) Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29:1969-1973. doi: 10.1093/molbev/mss075 PMID: 22367748
18. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, et al. (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37:937-943. PMID: 10074505
19. Mandelboim M, Glatman-Freedman A, Drori Y, Sherbany H, Pando R, Sefty H, et al. (2016) Ineffectiveness of the 2014-2015 H3N2 influenza vaccine. Oncotarget 7:1185-1192. doi: 10.18632/oncotarget. 6746 PMID: 26716420
20. Weil M, Shohat T, Bromberg M, Bassal R, Dichtiar R, Mandelboim M, et al. (2013) The dynamics of infection and the persistence of immunity to A (H1N1) pdm09 virus in Israel. Influenza Other Respir Viruses 7:838-846. doi: 10.1111/irv. 12071 PMID: 23280061
21. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X (2010) Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 28:2149-2156. doi: 10.1016/j.vaccine.2009.11.068 PMID: 20003926
22. Beran J, Wertzova V, Honegr K, Kaliskova E, Havlickova M, Havlik J, et al. (2009) Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example. BMC Infect Dis 9:2. doi: 10.1186/1471-2334-9-2 PMID: 19149900
23. Heikkinen T, Ikonen N, Ziegler T (2014) Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. Clin Infect Dis 59:1519-1524. doi: 10.1093/cid/ciu664 PMID: 25139969
24. Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, et al. (2013) Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis 208:544-553. doi: 10.1093/infdis/jit263 PMID: 23847058
25. Skowronski DM, Hamelin ME, Janjua NZ, De Serres G, Gardy JL, Rheaume C, et al. (2012) Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance. PLoS One 7:e38929. doi: 10.1371/journal.pone.0038929 PMID: 22745690
26. Skowronski DM, Hottes TS, De Serres G, Ward BJ, Janjua NZ, Sabaiduc S, et al. (2011) Influenza Beta/Victoria antigen induces strong recall of Beta/Yamagata but lower Beta/Victoria response in children primed with two doses of Beta/Yamagata. Pediatr Infect Dis J 30:833-839. doi: 10.1097/INF. 0b013e31822db4dc PMID: 21857263
27. Socan M, Prosenc K, Ucakar V, Berginc N (2014) A comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection. J Clin Virol 61:156-160. doi: 10.1016/j.jcv. 2014.06.018 PMID: 25034374
28. Tan Y, Guan W, Lam TT, Pan S, Wu S, Zhan Y, et al. (2013) Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010. J Virol 87:12447-12456. doi: 10. 1128/JVI.01039-13 PMID: 24027322